According to Rohto Pharmaceutical's latest financial reports the company's current earnings (TTM) are HK$2.22 B. In 2023 the company made an earning of HK$2.25 B an increase over its 2022 earnings that were of HK$1.97 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.